UnitedHealth/$UNH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About UnitedHealth
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Ticker
$UNH
Sector
Primary listing
NYSE
Employees
400,000
Headquarters
Website
UnitedHealth Metrics
BasicAdvanced
$312B
17.94
$19.22
0.48
$8.62
2.56%
Price and volume
Market cap
$312B
Beta
0.48
52-week high
$613.92
52-week low
$234.60
Average daily volume
8.8M
Dividend rate
$8.62
Financial strength
Current ratio
0.823
Quick ratio
0.461
Long term debt to equity
68.422
Total debt to equity
75.734
Dividend payout ratio (TTM)
44.61%
Interest coverage (TTM)
6.54%
Profitability
EBITDA (TTM)
29,242
Gross margin (TTM)
19.70%
Net profit margin (TTM)
4.04%
Operating margin (TTM)
6.06%
Effective tax rate (TTM)
17.27%
Revenue per employee (TTM)
$1,090,000
Management effectiveness
Return on assets (TTM)
5.36%
Return on equity (TTM)
17.48%
Valuation
Price to earnings (TTM)
17.94
Price to revenue (TTM)
0.719
Price to book
3.08
Price to tangible book (TTM)
3.08
Price to free cash flow (TTM)
18.009
Free cash flow yield (TTM)
5.55%
Free cash flow per share (TTM)
19.143
Dividend yield (TTM)
2.50%
Forward dividend yield
2.56%
Growth
Revenue change (TTM)
10.48%
Earnings per share change (TTM)
24.92%
3-year revenue growth (CAGR)
11.36%
10-year revenue growth (CAGR)
11.47%
3-year earnings per share growth (CAGR)
-1.98%
10-year earnings per share growth (CAGR)
11.79%
3-year dividend per share growth (CAGR)
11.61%
10-year dividend per share growth (CAGR)
17.29%
What the Analysts think about UnitedHealth
Analyst ratings (Buy, Hold, Sell) for UnitedHealth stock.
Bulls say / Bears say
UnitedHealth lifted its 2025 adjusted profit forecast to at least $16.25 per share after reporting third-quarter 2025 adjusted EPS of $2.92—exceeding analyst estimates—and highlighted 16% growth in Optum Rx, underscoring robust core performance (Reuters).
The insurer projects approximately 78% of its Medicare Advantage members will be enrolled in 4-star or higher-rated plans for 2026, a mix that is expected to drive substantial bonus payments and higher government reimbursements (Reuters).
UnitedHealth's strategic pivot in Medicare Advantage from membership volume to profitability—cutting back enrollments in lower-margin segments and focusing on high-star plans—has enabled the company to raise earnings forecasts and adopt a more sustainable growth model (WSJ).
UnitedHealth confirmed it is under criminal and civil investigation by the U.S. Department of Justice over Medicare billing practices in a regulatory filing, raising compliance risk and contributing to a share price decline of over 40% year-to-date (FT).
In July 2025 UnitedHealth reinstated its full-year 2025 profit forecast at $16 per share—far below the prior $26–$26.50 guidance and analysts’ $20.91 consensus—signaling persistent struggles in managing medical cost inflation and denting investor confidence (Reuters).
Underperformance in its Optum pharmacy benefit manager saw quarterly revenue fall 7% year-over-year due to legacy contract revisions, while Medicare Advantage medical cost trends are now expected to reach 7.5% in 2025 (up from just over 5%) and accelerate to nearly 10% next year, putting sustained pressure on margins (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2025.
UnitedHealth Financial Performance
Revenues and expenses
UnitedHealth Earnings Performance
Company profitability
UnitedHealth News
AllArticlesVideos
Calls of the Day: Uber, Datadog, UnitedHealth, Chubb and FTAI Aviation
CNBC Television2 days ago
Heard on the Street: UnitedHealth and CVS are pruning their Medicare Advantage businesses to favor profit over size
WSJ2 days ago
UnitedHealth Group's Recovery in Full Swing: Buy While It's Down
MarketBeat2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for UnitedHealth stock?
UnitedHealth (UNH) has a market cap of $312B as of October 31, 2025.
What is the P/E ratio for UnitedHealth stock?
The price to earnings (P/E) ratio for UnitedHealth (UNH) stock is 17.94 as of October 31, 2025.
Does UnitedHealth stock pay dividends?
Yes, the UnitedHealth (UNH) stock pays dividends to shareholders. As of October 31, 2025, the dividend rate is $8.62 and the yield is 2.56%. UnitedHealth has a payout ratio of 44.61% on a trailing twelve-month basis.
When is the next UnitedHealth dividend payment date?
The next UnitedHealth (UNH) dividend payment date is unconfirmed.
What is the beta indicator for UnitedHealth?
UnitedHealth (UNH) has a beta rating of 0.48. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.